Shares in Chinese robotics company Unitree closed 460% above their offer price in the first mainland listing of a humanoid-robot maker. The humanoid-robot maker raised about $904 million, but most industry shipments still serve demonstrations and research rather than scaled work. Unitree shares rose as much as 629% before closing 460% higher at 845 yuan on Shanghai's STAR market.
The company raised about 6.1 billion yuan, or $904 million, with an offer price of 150.80 yuan per share. Unitree and rival AGIBOT each shipped more than 5,000 of the roughly 15,000 humanoid robots delivered globally in 2025, according to Omdia. Shipment totals show manufacturing momentum, while the use cases show market immaturity. A robot delivered for a conference demonstration is not equivalent to one completing repeatable production work under safety constraints.
Chinese humanoid makers shipped about 18,500 units in the first half of 2026, Omdia estimated. Analysts cautioned that many robots remain in demonstrations, performances and research rather than dependable commercial work. Unitree reported about $250 million in 2025 revenue, more than 40% from overseas, and said IPO proceeds will fund research and manufacturing. The U.S. import restriction adds a concrete business limit to Unitree's global ambition. Future revenue will depend on access to other markets and on whether buyers move from experimentation to recurring deployments.
China has made advanced robotics a strategic industrial priority and has strong manufacturing scale. The United States barred imports of new foreign-made humanoid and quadruped robots in July on national-security grounds.
A first-day stock price can reflect scarcity and speculation rather than long-term operating performance. The current evidentiary limit is that the debut does not establish sustainable valuation, profitable deployment or reliability across industrial tasks.
The next factual record will come from post-IPO financial disclosures and order mix and independent field data on uptime, safety and return on investment. Until those records appear, the account remains bounded by the cited reporting, measurements and explicitly attributed statements.